Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Visium Asset Management Reports 5.5% New Stake In OHR Pharmaceutical Inc (OHRP)

Jacob Gottlieb thinks OHR Pharmaceutical Inc (NASDAQ:OHRP) is a good investment and has initiated a new position for his fund, Visium Asset Management. According to a recent filing with the Securities and Exchange Commission, Gottlieb and Visium have acquired 1.22 million shares, amassing 5.2% of the company’s common stock.

OHR Pharmaceutical Inc

Both Cliff Asness and Israel Englander have become fans of OHR Pharmaceutical Inc (NASDAQ:OHRP) and have initiated positions for their respective funds. Englander’s Millennium Management has acquired a little over 900,000 shares during the first quarter of 2014, as reported in the fund’s latest 13F filing. The position built by Asness during the same period for AQR Capital Management is much smaller – 13,100 shares. Geoffrey Raynor is also bullish on OHR Pharmaceutical Inc (NASDAQ:OHRP) and has acquired approximately 57,600 shares for his fund, Q Investments (Specter Holdings), according to its latest 13F filing.

Disclosure: none.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!